(Q36333915)

13 August 2017

1 reference

title

Inflammation, thrombosis and acute coronary syndromes (English)

1 reference

13 August 2017

0 references

0 references

Angela M Carter

1

1 reference

PubMed ID

16334592

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Diabetes and Vascular Disease Research

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

3

1 reference

13 August 2017

113-121

1 reference

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

13 August 2017

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Pathophysiology of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

New Markers of Inflammation and Endothelial Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

The molecular role of mast cells in atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Proteolysis of the pericellular matrix: a novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Platelet-collagen interaction: is GPVI the central receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

The molecular physiology and pathology of fibrin structure/function

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

The impact of the inflammatory response on coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Plasminogen-activator inhibitor type 1 and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Complement activation by C-reactive protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Regulation of complement activation by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Complement. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Processes in atherogenesis: complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

The complement system: a pathway linking host defence and adipocyte biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Molecular basis for a link between complement and the vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Influence of C3 deficiency on atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Interleukin-6 exacerbates early atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Restraint stress elevates the plasma interleukin-6 levels in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

White blood cell count and cardiovascular disease. Insights from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Leukocyte count and risk of major coronary heart disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Cons

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

Which white blood cell subtypes predict increased cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.018

21 January 2018

Identifiers

DOI

10.3132/DVDR.2005.018

1 reference

13 August 2017

1 reference

PubMed ID

16334592